BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tian J, Xu Y, Xiong Y, Zuo L, Zhou M, Cao C, Huang X, Wang J. Metabolomics combined with network pharmacology to explore the mechanisms of modified Guishen pill to ameliorate polycystic ovary syndrome. Comput Biol Med 2022;148:105790. [PMID: 35839542 DOI: 10.1016/j.compbiomed.2022.105790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi S, Zhao S, Tian X, Liu F, Lu X, Zang H, Li F, Xiang L, Li L, Jiang S. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment. Comput Biol Med 2023;157:106777. [PMID: 36924737 DOI: 10.1016/j.compbiomed.2023.106777] [Reference Citation Analysis]
2 Ataabadi MS, Bahmanpour S, Yousefinejad S, Alaee S. Blood volatile organic compounds as potential biomarkers for poly cystic ovarian syndrome (PCOS): An animal study in the PCOS rat model. J Steroid Biochem Mol Biol 2023;226:106215. [PMID: 36332782 DOI: 10.1016/j.jsbmb.2022.106215] [Reference Citation Analysis]
3 Han H, Qian C, Zong G, Liu H, Wang F, Tao R, Cheng P, Wei Z, Zhao Y, Lu Y. Systemic pharmacological verification of Salvia miltiorrhiza-Ginseng Chinese herb pair in inhibiting spontaneous breast cancer metastasis. Biomedicine & Pharmacotherapy 2022;156:113897. [DOI: 10.1016/j.biopha.2022.113897] [Reference Citation Analysis]